Human thiopurine S-methyltransferase (TPMT) pharmacogenetics: Variant allozyme aggresome formation.

被引：1
|
作者：
Wang, L [1 ]
Weinshilboum, R [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.12.257
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P95 / P95
页数：1
相关论文
共 50 条
  • [21] Common Polymorphism's Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
    Azad, Mehdi
    Kaviani, Saeid
    Soleimani, Masoud
    Noruzinia, Mehrdad
    Hajfathali, Abbas
    YAKHTEH, 2009, 11 (03): : 311 - 316
  • [22] Thiopurine methyltransferase (TPMT) pharmacogenetics: Polymorphism characterization.
    Otterness, D
    Szumlanski, C
    Wood, T
    Lennard, L
    Klemetsdal, B
    Aarbakke, J
    ParkHah, J
    Iven, H
    Branum, E
    OBrien, J
    Weinshilboum, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : OIB4 - OIB4
  • [23] THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME.
    Feng, Q.
    Vannaprasaht, S.
    Peng, Y.
    Angsuthum, S.
    Avihingsanon, Y.
    Yee, V. C.
    Tassaneeyakul, W.
    Weinshilboum, R. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S6 - S6
  • [24] Comprehensive assessment of thiopurine S-methyltransferase (TPMT) alleles in three ethnic populations
    Evans, WE
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (05) : 335 - 336
  • [25] THIOPURINE METHYLTRANSFERASE (TPMT) PHARMACOGENETICS - CLONING OF HUMAN LIVER CDNA AND PROCESSED PSEUDOGENE
    LEE, D
    SZUMLANSKI, C
    HOUTMAN, J
    HONCHEL, R
    ROJAS, K
    OVERHAUSER, J
    WIEBEN, E
    WEINSHILBOUM, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 205 - 205
  • [26] Thiopurine S-methyltransferase pharmacogenetics: Genotype to phenotype correlation in the Slovenian population
    Milek, M.
    Murn, J.
    Jaksic, Z.
    Bajalo, J. Lukac
    Jazbec, J.
    Rascan, I. Mlinaric
    PHARMACOLOGY, 2006, 77 (03) : 105 - 114
  • [27] Genotype-phenotype relationship of thiopurine S-methyltransferase (TPMT) in a reference population
    Johnson-Davis, K. L.
    Melis, R.
    Lyon, E.
    Juenke, J.
    McMillin, G.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (03) : 481 - 482
  • [28] Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population
    Milek, M
    Jaksic, Z
    Bajalo, JL
    Mlinaric-Rascan, I
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 : S157 - S159
  • [29] TPMT*3 is the most prevalent mutant associated with thiopurine S-methyltransferase (TPMT) deficiency in Caucasians.
    Yates, CR
    Krynetski, E
    Tai, HL
    Loennechen, T
    Evans, WE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII37 - PII37
  • [30] Thiopurine methyltransferase (TPMT) pharmacogenetics: Mechanism for loss of activity by a splice junction variant allele.
    Otterness, DM
    Szumlanski, CL
    Wood, TC
    Weinshilboum, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 224 - 224
12345